Biopsy Devices Market Size, Share, Growth Analysis, By Product (Liquid Biopsy Instruments, Needle-Based Biopsy Instruments), By Guidance Technique (Non-Image-Guided Biopsy, Image-Guided Biopsy techniques), By Application, By End Use, By Region - Industry Forecast 2024-2031

Global Biopsy Devices Market size was valued at USD 5.79 billion in 2022 and is poised to grow from USD 6.60 billion in 2023 to USD 18.83 billion by 2031, growing at a CAGR of 14.00% in the forecast period (2024-2031).

The global biopsy devices market all over the world is very competitive with many international companies competing for market share through innovation and strategic partnerships. Leading players include Medtronic, Boston Scientific, Becton Dickinson which have advanced technologies and wide range of products. They invest in research and development to make their devices more precise and to broaden their geographical presence since the demand has been rising. Strategic acquisitions and collaborations are also important factors in sustaining competitive advantage and driving growth. 'Becton, Dickinson and Company (US) ', 'Danaher Corporation (US) ', 'B. Braun Melsungen AG (Germany) ', 'Cardinal Health, Inc. (US) ', 'Hologic, Inc. (US) ', 'Olympus Corporation (Japan) ', 'Boston Scientific Corporation (US) ', 'Fujifilm Corporation (Japan) ', 'Medtronic Plc (Ireland) ', 'Stryker Corporation (US) ', 'Cook Group Incorporated (US) ', 'Argon Medical Devices (US) ', 'Inrad, Inc. (US) ', 'Conmed Corporation (US) ', 'Teleflex Incorporated (US) ', 'Qiagen N.V. (Netherlands) ', 'Thermo Fisher Scientific, Inc. (US) ', 'Summit Medical LLC (US) ', 'Hill-Rom Holdings, Inc. (US) ', 'Gallini S.R.L (Italy) ', 'Transmed7, LLC (US) ', 'TSK Laboratory International (Japan) ', 'Merit Medical Systems, Inc. (US) ', 'Dr. Japan Co., Ltd. (Japan) ', 'Izi Medical Products (US) ', 'Planmed Oy (Finland) ', 'Advin Health Care (India) ', 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Illumina, Inc. (US)'

Global biopsy devices market is significantly driven by the increasing global cancer incidence. With cancer increasing, there is a corresponding need for precise and early diagnostic tools to help in timely healing. Therefore, this surge in demand for biopsy procedures increases the growth of innovative biopsy devices market.

Rise of Image-Guided Biopsy Techniques: As their accuracy has increased and they are able to image in real time, image-guided biopsy techniques like ultrasound and CT scan guidance have gained popularity rapidly. With the application of these technologies, patient outcomes and diagnostic accuracy are improving thereby leading to growth in the market for biopsy equipment.

The global biopsy devices market is primarily dominated by North America due to its advanced health care facilities, better use of innovative technologies and strong research & development endeavors. This region boasts a well-established network of health care providers and good access to state-of-the-art diagnostic apparatus thereby propelling the consumption of modernized biopsy devices. At the same time, there is a rise in the number of cancer cases and also more focus on early diagnosis and accuracy, which can help improve market development. In fact, North America is the leading region globally when it comes to the global biopsy devices market due to favorable government policies, increased spending on health care and successful companies in the area.